Indications
Irritable bowel syndrome and constipation Tegaserod is indicated for the symptomatic treatment of irritable bowel syndrome with constipation (IBS-C) in patients whose main symptoms are constipation and abdominal pain or discomfort. The maximum duration of treatment is 12 weeks and treatment should be discontinued if there has been no response after 4 weeks.
Dosage And Administration
General recommended dosage for adult: Tegaserod 6 mg twice daily taken orally with a glass of water 30 minutes before meal. The maximum duration of treatment is 12 weeks and treatment should be discontinued after 4 weeks if no response has occurred.Use in elderly: Dose adjustment is not necessary when administering Tegaserod to patients over 65 years old. Use in children: There is no clinical trial in document to safety and efficacy of tegaserod in children. Therefore, it is not recommended for use in children.
Side Effects
Abdominal pain, diarrhea, nausea, flatulence, headache, fatigue, back pain etc.
Precautions And Warnings
Diarrhea was reported in some of the patients receiving Tegaserod in the Phase III clinical studies. Caution is required in patients in whom increased diarrhea could have negative effects. Patients who are currently experiencing or frequently experience diarrhea should not initiate therapy with Tegaserod.
Pregnancy And Lactation
Pregnancy: In view of limited experience in human, use of Tegaserod during pregnancy is not recommended.Nursing mothers: Tegaserod should not be prescribed to nursing mothers.